There were many moving talks at TEDxVienna. Some that particularly struck me were on the refugee situation and also one on children who are sold. Those of us here in America and other parts further removed from the front lines of the refugee situation have not fully grasped the scope of the problem, the humanitarian crisis […]
Part 2 @TEDxVienna: putting faces on refugee crisis, children for sale Read More »
I’m on my way back home from Vienna, Austria where I attended TEDxVienna. This was my first time giving a TED talk. The first day I arrived I had a few hours to wander around the city as a jetlagged zombie of sorts, but a happy one. Vienna is home to some great food and
Part 1 @TEDxVienna: Amazing City & People Read More »
I’ve written a new book on human genetic modification. This is my second book as the first one was Stem Cells: An Insider’s Guide, which is currently the top stem cell book on Amazon. The new book is called GMO Sapiens: The Life-Changing Science of Designer Babies. You can pre-order it here at Amazon or over here at my publisher’s
GMO Sapiens book teaser: time to talk frankly on human genetic modification Read More »
By Jeanne Loring Last Tuesday I visited the FDA headquarters in Maryland, for a meeting called Public Meeting on Patient-Focused Drug Development for Huntington’s and Parkinson’s Diseases. The FDA holds about 6 meetings on different diseases each year, inviting patients and advocates to speak while a panel of FDA directors listens. The FDA representatives at
Guest Post from Jeanne Loring: Patients talk stem cells. The FDA listens. Read More »
The path to the clinic is a slow and arduous activity, frustrating not only to the researcher and patient, but investors and biotech companies. Successful clinical translation of technologies requires a balance of science, streamlined translation and funding. To develop fantastic science and then realise the most important components cannot be adapted to the clinical
Biotech Talks #ISSCR2015: StemCells Inc, Semma, ViaCyte, & Le Blanc Read More »
Organoids are pretty big in stem cells right now with the last couple of years having attracted a lot of media attention on mini lungs, mini brains, mini kidneys, mini guts and more, giving the impression that scientists know how to specify and organise cells into mini functional organs in the lab. Organoids have become
Carla Kim & Hans Clevers talks on organoids at #ISSCR2015 Read More »
The day of plenary is the most enjoyable in my view including at ISSCR 2015 on the first day with a Yamanaka talk. You don’t need to make the choice between sessions and the judgement on the viability of shifting sessions versus staying put and listening to the slightly less relevant. ISSCR 2015 plenary was,
Overview of Yamanaka Talk at #ISSCR2015 by Heather Main Read More »
As CRISPR gene editing technology has advanced in the last few years, the number of genetically modified animals made with this system has steadily increased. Some are very interesting and useful for science. At the same time especially when they are little, they can be very cute. A nickname is going around for these GM
CRISPR critters: Cute pics of Cas9 gene edited animals Read More »
Recently I was at the World Alliance Forum in San Francisco (WAFSF), a great meeting on stem cells and regenerative medicine. WAFSF had some excellent talks and I saw one session on the use of stem cells to treat vision impairment that was particularly striking. World Alliance Forum in San Francisco (WAFSF) This session’s all-star lineup included Drs. David
WAFSF stem cell vision talks: Hinton, Tsukamoto, Klassen, Takahashi Read More »
This is Part 2 of my interview with ALS and stem cell advocate, Ted Harada. You can read Part 1 of my talk with Ted on where things stand today with ALS, the FDA, and the Ice Bucket Challenge. What’s your opinion of the “Right To Try” law in Colorado and the concept more generally?
Interview with Ted Harada Part 2: Right To Try, Neuralstem, and How He’s Doing Read More »